VAV3
Further reading
Hobert O, Schilling JW, Beckerle MC, et al. (1996). "SH3 domain-dependent interaction of the proto-oncogene product Vav with the focal contact protein zyxin". Oncogene . 12 (7): 1577– 81. PMID 8622875 .
Tamma SM, Chirmule N, Yagura H, et al. (1997). "CD4 cross-linking (CD4XL) induces RAS activation and tumor necrosis factor-alpha secretion in CD4+ T cells" . Blood . 90 (4): 1588– 93. doi :10.1182/blood.V90.4.1588 . PMID 9269777 .
Trenkle T, Welsh J, Jung B, et al. (1998). "Non-stoichiometric reduced complexity probes for cDNA arrays" . Nucleic Acids Res . 26 (17): 3883– 3891. doi :10.1093/nar/26.17.3883 . PMC 147802 . PMID 9705494 .
Movilla N, Bustelo XR (1999). "Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins" . Mol. Cell. Biol . 19 (11): 7870– 85. doi :10.1128/mcb.19.11.7870 . PMC 84867 . PMID 10523675 .
Trenkle T, McClelland M, Adlkofer K, Welsh J (2000). "Major transcript variants of VAV3, a new member of the VAV family of guanine nucleotide exchange factors". Gene . 245 (1): 139– 149. doi :10.1016/S0378-1119(00)00026-3 . PMID 10713454 .
Zeng L, Sachdev P, Yan L, et al. (2001). "Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation" . Mol. Cell. Biol . 20 (24): 9212– 9224. doi :10.1128/MCB.20.24.9212-9224.2000 . PMC 102179 . PMID 11094073 .
Inabe K, Ishiai M, Scharenberg AM, et al. (2002). "Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation" . J. Exp. Med . 195 (2): 189– 200. doi :10.1084/jem.20011571 . PMC 2193613 . PMID 11805146 .
Yabana N, Shibuya M (2002). "Adaptor protein APS binds the NH2-terminal autoinhibitory domain of guanine nucleotide exchange factor Vav3 and augments its activity" . Oncogene . 21 (50): 7720– 7729. doi :10.1038/sj.onc.1205927 . PMID 12400014 .
Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs" . Nat. Genet . 36 (1): 40– 45. doi :10.1038/ng1285 . PMID 14702039 .
Zakaria S, Gomez TS, Savoy DN, et al. (2004). "Differential regulation of TCR-mediated gene transcription by Vav family members" . J. Exp. Med . 199 (3): 429– 434. doi :10.1084/jem.20031228 . PMC 2211790 . PMID 14757747 .
Pearce AC, Senis YA, Billadeau DD, et al. (2005). "Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen" . J. Biol. Chem . 279 (52): 53955– 53962. doi :10.1074/jbc.M410355200 . PMID 15456756 .
Charvet C, Canonigo AJ, Billadeau DD, Altman A (2005). "Membrane localization and function of Vav3 in T cells depend on its association with the adapter SLP-76" . J. Biol. Chem . 280 (15): 15289– 15299. doi :10.1074/jbc.M500275200 . PMID 15708849 .
Lyons LS, Burnstein KL (2006). "Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity" . Mol. Endocrinol . 20 (5): 1061– 1072. doi :10.1210/me.2005-0346 . PMID 16384856 . S2CID 43049417 .
Dong Z, Liu Y, Lu S, et al. (2006). "Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer" . Mol. Endocrinol . 20 (10): 2315– 2325. doi :10.1210/me.2006-0048 . PMID 16762975 .